Investor Relations

Recent Event

Cantor Global Healthcare Conference

Company Overview

BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, colorectal cancer, and cystic fibrosis. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Latest Financial Results

Latest Annual Report

For Fiscal Year Ending Dec 31, 2020

Investor Contact Information

Company

BiomX, Inc.
7 Pinhas Sapir St.
Floor 2
Ness Ziona 7414002
Israel
info@biomx.com

Investor Relations

Assaf Oron
Chief Business Officer
T: +972542228901
assafo@biomx.com

Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.